Q2 2025 Teladoc Health Inc Earnings Call Transcript
Key Points
- Teladoc Health Inc (TDOC) reported consolidated revenue and adjusted EBITDA at the higher end of their guidance ranges, reflecting strong performance and disciplined execution.
- The company launched Wellbound, a new employee assistance program offering mental health and well-being support, which has seen early interest in the US integrated care market.
- Teladoc Health Inc (TDOC) enhanced its cardio metabolic health program with new features, including connected devices and registered dietitian access, aiming for a comprehensive approach to diabetes, hypertension, and obesity.
- The company exceeded 100 million US integrated care members, providing additional opportunities for service growth over time.
- International business accounts for over 15% of consolidated revenue, with steady double-digit growth and expansion into new geographies, including hybrid care models for public health systems.
- Second quarter consolidated revenue was down 1.6% year over year, driven by a decline at BetterHelp, despite growth in integrated care revenue.
- The BetterHelp segment faced headwinds in the US cash pay business, with a high single-digit percentage decline in users compared to the previous year.
- Customer acquisition costs increased, and there were fewer gross user ads, impacting the cash pay business.
- The transition to insurance coverage for BetterHelp is expected to result in lower gross margins compared to the legacy cash pay business.
- The company faces ongoing challenges in the health plan channel, with pressure on chronic care program enrollment due to contract losses and competitive dynamics.
Good afternoon. Thank you for attending today's Teladoc Health second quarter 2025 earnings call. My name is Victoria and I'll be your moderator today. (Operator Instructions) I would now like to pass the conference over to Mike Minchak, Head of Investor Relations for Teladoc Health. Thank you may proceed.
Thank you, and good afternoon. Today, after the market closes, we issued a press release announcing our second quarter 2025 financial results. This press release and the accompanying slide presentation are available in the Investor Relations section of the teladochealth.com website.
On this call to discuss our results are Chuck Divita, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. During this call, we will also discuss our outlook, and our prepared remarks will be followed by a question-and-answer session.
Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating our performance. Details
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
